Role of Rucaparib in the Treatment of Prostate Cancer: Clinical Perspectives and Considerations
Maximillian S Wu, Hanan Goldberg Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USACorrespondence: Hanan Goldberg, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, 13520, USA, Tel +1-315-271-4173, Email gohanan@gmail.comAbstract: Prostate cancer is one of...
Main Authors: | Wu MS, Goldberg H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-11-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/role-of-rucaparib-in-the-treatment-of-prostate-cancer-clinical-perspec-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures
by: Ciara S. McNevin, et al.
Published: (2022-09-01) -
The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration‐resistant prostate cancer in real‐world clinical practice: The multi‐institutional observational ZENSHIN study
by: Hiroji Uemura, et al.
Published: (2023-03-01) -
PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers
by: Diego Teyssonneau, et al.
Published: (2022-03-01) -
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer
by: Peter H. J. Slootbeek, et al.
Published: (2023-05-01) -
A Meta-Analysis of Randomized Clinical Trials Assessing the Efficacy of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer
by: Zakaria Alameddine, et al.
Published: (2023-10-01)